about
Interventions to enhance adherence to medications in patients with heart failure: a systematic reviewDo the malnutrition universal screening tool (MUST) and Birmingham nutrition risk (BNR) score predict mortality in older hospitalised patients?Effect of vitamin D on blood pressure: a systematic review and meta-analysis.Social, environmental and psychological factors associated with objective physical activity levels in the over 65sEffect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis.Effect of short-term vitamin D supplementation on markers of vascular health in South Asian women living in the UK--a randomised controlled trial.Exercise training as a therapy for chronic heart failure: can older people benefit?Family caregiving and congestive heart failure. Review and analysis.Development of a risk score to guide brain imaging in older patients admitted with falls and confusion.Validation of an individualised quality of life measure in older day hospital patientsThe under-representation of older people in clinical trials: barriers and potential solutions.Psychological theory in an interdisciplinary context: psychological, demographic, health-related, social, and environmental correlates of physical activity in a representative cohort of community-dwelling older adults.Vitamin D supplementation did not prevent influenza-like illness as diagnosed retrospectively by questionnaires in subjects participating in randomized clinical trials.Vitamin D and cardiovascular prevention.Meta-analysis of B-type natriuretic peptide's ability to identify stress induced myocardial ischemia.Vitamin D in chronic heart failure.Can vitamin D deficiency cause diabetes and cardiovascular diseases? Present evidence and future perspectives.The effects of vitamin D supplementation on physical function and quality of life in older patients with heart failure: a randomized controlled trial.Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial.Efficacy and cost of an exercise program for functionally impaired older patients with heart failure: a randomized controlled trial.Effects of vitamin D supplementation on markers of vascular function after myocardial infarction--a randomised controlled trial.Adherence to angiotensin-converting-enzyme inhibitors and illness beliefs in older heart failure patients.Effects of an exercise intervention for older heart failure patients on caregiver burden and emotional distress.Using a sentinel adverse incident audit on a Medicine for the Elderly ward.Health and welfare of older people in care homes.The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial.Predicting mortality using two renal function estimation methods in hospitalised stroke patients.Defining the nutritional status and dietary intake of older heart failure patients.Allopurinol use is associated with greater functional gains in older rehabilitation patients.Drug trials and older people: time to embrace the complexity of age.Hypothetical economic analysis of screening for left ventricular hypertrophy in high-risk normotensive populations.Adenocarcinoma of the duodenum with liver metastases. Complete remission and long-term survival with 5-fluorouracil chemotherapy--a case report.Age is not a significant risk factor for failed trial of beta-blocker therapy in older patients with chronic heart failure.Day length and weather conditions profoundly affect physical activity levels in older functionally impaired people.Using an individualised quality of life measure in older heart failure patients.Trends in function and postdischarge mortality in a medicine for the elderly rehabilitation center over a 10-year period.Variations in disability and quality of life with age and sex between eight lower income and middle-income countries: data from the INDEPTH WHO-SAGE collaboration.B-type natriuretic peptide is associated with mortality in older functionally impaired patients.Pilot study of an exercise intervention suitable for older heart failure patients with left ventricular systolic dysfunction.Long-term follow-up of very old heart failure patients enrolled in a trial of exercise training.
P50
Q27027670-0C431866-345B-412D-BED9-FB10DEE179B9Q33375178-9BCEC14C-341F-4535-B971-D7A1435CAFC4Q33479951-FD1933BB-77D5-4A3E-8E02-6166BAC0987AQ34168457-E564B482-2C70-444D-8188-FAA4586FC14DQ34225331-83C7BD57-9E50-4222-B37E-318A314A8044Q35001624-C13D64F7-BED1-4447-86BF-5C371885F649Q35129801-490F26EB-F075-44C4-B94C-523F1D604A29Q36142239-1581F399-F3D3-4F77-BF22-D65988230198Q36323911-0D05D7B5-6DED-48CC-8ABB-4E09EEEB017FQ36639751-DADDB6CC-518B-4263-BEC0-15C920C9C3DAQ37097887-818C1E8D-6DFF-4F14-AE57-9C9C2D7A1B89Q37357803-AD5E88E6-0DCE-4E27-BCA6-0D47B101E8F8Q37567584-9DC79BC0-5460-4BE8-9387-EC0E4963BB9EQ37765609-3060216B-60C8-42F9-A562-0E8A2D133F6DQ37823976-B01F0FD2-2A6A-41E4-B116-14D4AC2FFAE2Q37843864-891F334A-CFAE-448D-B43F-BAF89A84667DQ37977731-63FADD6F-EC90-4D5C-BE86-CFF9AE69F390Q38376128-CE99EC3D-78D4-4B31-9D4B-BF666302422FQ38446478-45D602D6-CEFD-4AF9-9873-F7B984AFED28Q38477005-DF575986-307C-436B-B8C6-747D56714840Q39635073-CB09ADB2-4A5F-4A4C-ACEA-1AEE6E87A5CBQ39984653-F6879656-8066-48BF-BCDB-596BAFDE1F63Q40295111-65D3F48A-C93B-4E03-83C7-EA335112A973Q42507056-689B4020-4372-4846-92DD-4EF7FFC5034EQ42801913-FD4D91C2-5BB2-432D-BA7A-8F5AD46EE990Q42993191-548E5A56-C73B-4FD5-8CC1-111BFB6FD337Q43700591-AC9259EE-84AD-4E8A-88CF-3E453483CCA5Q44067044-A1D68BED-9D36-436C-9DC9-4B065F4728DDQ44308400-0151E55B-50EB-41FB-9489-DCEBCDF8314CQ44640310-625C3F80-B553-4AED-9C99-AA720EB52BD2Q44745345-4B8FFF9D-460A-43CA-A5DD-310D689E3CFBQ44780440-787FD243-7823-4B78-82DE-DB5C614C436DQ45274042-3AACFD1B-2097-4DEC-A26A-78041F618AB7Q45765287-6E6365EA-FC76-4F14-8ECA-F32AB22D318BQ46183623-BB9B8B0D-4AA3-4DA6-8179-07E2AAD13EB4Q46722765-E7E9563C-5193-4D01-9ABF-3D72A43A24F0Q47559683-EBF86B70-1AC0-4B18-B193-AAE6D0D0937DQ48704574-79D28DF6-538D-4355-91FE-454BF1D7EAD3Q50802067-B8CC4DD1-45A1-4A97-8A92-49E8F3107182Q50894962-551E6221-F374-4B34-B57E-229B8356B107
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Miles D Witham
@bar
Miles D Witham
@de
Miles D Witham
@fr
Miles D Witham
@nl
Miles D Witham
@sl
Miles D. Witham
@en
Miles D. Witham
@es
type
label
Miles D Witham
@bar
Miles D Witham
@de
Miles D Witham
@fr
Miles D Witham
@nl
Miles D Witham
@sl
Miles D. Witham
@en
Miles D. Witham
@es
altLabel
Miles D. Witham
@bar
Miles D. Witham
@de
Miles D. Witham
@en
Miles D. Witham
@fr
prefLabel
Miles D Witham
@bar
Miles D Witham
@de
Miles D Witham
@fr
Miles D Witham
@nl
Miles D Witham
@sl
Miles D. Witham
@en
Miles D. Witham
@es
P106
P1153
6701420884
P21
P31
P496
0000-0002-1967-0990